Seegene begins exporting its latest COVID-19 variant tests around the world to help contain spread of pandemic
Seegene can produce 300,000 variant diagnostic test kits, capable of testing 30 million people every month
Seegene can produce 300,000 variant diagnostic test kits, capable of testing 30 million people every month
Highly complementary cell counting and analysis capabilities bolster preclinical portfolio and enhance QA/QC capabilities in cell and gene therapy and biologics manufacturing
The availability of an International Standard (IS) for antibodies facilitates the standardization of SARS-CoV-2 serological methods
Bees are in decline because of intensive farming, pesticide prevalence and climate change – but human welfare depends on them
Platform poised to be first CLIA-waived CRISPR-based, point-of-care COVID-19 device with central-lab performance, developed in collaboration with Sherlock Biosciences
In this guest article by RayBiotech Life, learn how to easily obtain IHC positive controls for different pathologies without the need for patient samples
The independent study is being led by Southampton University Health Sciences
Their findings show that Paleocene mammals had more muscular builds than those from the Cretaceous or present day
License agreement to enhance GenScript’s CRISPR offering for gene and cell therapy research
In a Phase 3 trial, the vaccine was 100% effective and generally well tolerated in participants aged 12 to 15 years
The findings could lead to faster, more secure memory storage, in the form of antiferromagnetic bits
Labs processing 2,000 to 5,000 tests a day can finally enjoy the benefits of Total Laboratory Automation (TLA) with a compact workflow-automation solution that fits needs